Prostate Cancer (Very Low Risk) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Prostate Cancer (Very Low Risk)
A diagnosis of very low risk prostate cancer can be unsettling, but it often means a manageable condition that may not require immediate aggressive treatment. Understanding your options is key. At TheDrugClub, we believe financial stress shouldn't add to health worries, which is why our prescription savings membership helps make managing your health more affordable.
Receiving a prostate cancer diagnosis can be a challenging moment, but for many, it's categorized as "very low risk." This classification is given when the cancer is small, slow-growing, confined entirely within the prostate gland, and has a low Gleason score (typically 6 or less). Crucially, very low risk prostate cancer often does not pose an immediate threat to a man's health or lifespan, and many men live for years without it ever causing symptoms or spreading.
For those diagnosed with very low risk prostate cancer, the primary management approach is often active surveillance. This involves carefully monitoring the cancer's progression through regular PSA (prostate-specific antigen) blood tests, digital rectal exams (DREs), and periodic repeat biopsies. The goal is to avoid unnecessary treatments and their potential side effects, intervening only if there are signs the cancer is growing or becoming more aggressive.
If the cancer shows signs of progression or if a patient prefers active intervention, common treatments include radiation therapy (such as external beam radiation or brachytherapy, which involves implanting radioactive seeds) or surgery (radical prostatectomy, the removal of the prostate gland). While less common for very low risk cases initially, medications like hormone therapy (e.g., Lupron, Eligard) or newer oral drugs (e.g., Xtandi, Zytiga) may be used for higher-risk or advanced prostate cancer, or to manage side effects of other treatments. Even medications for managing related prostate health issues or diagnostic procedures can incur costs.
This is where TheDrugClub steps in. Our mission is to make necessary prescriptions more accessible and affordable. For just $19.95 a
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.